Latest News

 Filter by Provider

Clothing company Kontoor Brands (NYSE:KTB) announced better-than-expected revenue in Q2 CY2025, with sales up 8.5% year on year to $658.3 million. The company’s full-year revenue guidance of $3.11 billion at the midpoint came in 1.6% above analysts’ estimates. Its non-GAAP profit of $1.21 per share was 46.1% above analysts’ consensus estimates.

Pre-market futures were at peak highs just ahead of new economic prints this morning, but we remain in healthy, positive territory.

Doughnut chain Krispy Kreme (NASDAQ:DNUT) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 13.5% year on year to $379.8 million. Its non-GAAP loss of $0.15 per share was significantly below analysts’ consensus estimates.

I think precious metals miners are about to turn lower. Let's take a look at GDX and GDXJ, respectively.

DraftKings Inc (NASDAQ:DKNG) shares are trading lower Thursday after the company reported financial results for the second quarter. Shares initially moved higher on the report before reversing course and turning negative. Here's what you need to know.

Hair care company Olaplex (NASDAQ:OLPX) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 2.3% year on year to $106.3 million. The company expects the full year’s revenue to be around $420.5 million, close to analysts’ estimates. Its GAAP loss of $0.01 per share was in line with analysts’ consensus estimates.

Construction and construction materials company Granite Construction (NYSE:GVA) missed Wall Street’s revenue expectations in Q2 CY2025 as sales rose 4% year on year to $1.13 billion. On the other hand, the company’s full-year revenue guidance of $4.45 billion at the midpoint came in 3.5% above analysts’ estimates. Its non-GAAP profit of $1.93 per share was 13.9% above analysts’ consensus estimates.

Water management company Advanced Drainage Systems (NYSE:WMS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1.8% year on year to $829.9 million. The company expects the full year’s revenue to be around $2.9 billion, close to analysts’ estimates. Its non-GAAP profit of $1.95 per share was 10.9% above analysts’ consensus estimates.

Bedding manufacturer Somnigroup (NYSE:SGI) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 52.5% year on year to $1.88 billion. Its non-GAAP profit of $0.53 per share was 3.6% above analysts’ consensus estimates.

Datadog CEO Olivier Pomel said that at the end of Q2, the company has approximately 3,850 customers generating at least $100,000 in annual recurring revenue.

AppLovin delivered another quarter of red-hot growth.

Wendy's reports Q2 results Friday, Aug 8. Here are the analyst estimates and key items to watch, including an upcoming Netflix partnership.

Government services provider Maximus (NYSE:MMS) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 2.5% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.43 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $2.16 per share was 40.7% above analysts’ consensus estimates.

BlackSky's Q2 report was pretty darn bad.

Theme park operator United Parks & Resorts (NYSE:PRKS) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 1.5% year on year to $490.2 million. Its GAAP profit of $1.45 per share was 19.5% below analysts’ consensus estimates.

Fast-food company Restaurant Brands (NYSE:QSR) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 15.9% year on year to $2.41 billion. Its non-GAAP profit of $0.94 per share was 2.8% below analysts’ consensus estimates.

D-Wave Quantum Inc. opened in the red this morning, even after reporting better-than-expected revenue for its second financial quarter. The quantum technology company also recorded a sharp sequential increase in cash reserves.

Household products company Spectrum Brands (NYSE:SPB) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 10.2% year on year to $699.6 million. Its non-GAAP profit of $1.24 per share was in line with analysts’ consensus estimates.

ConocoPhillips (NYSE: COP) reported Q2 2025 financial results. Read the transcripts from the earnings call brought to you by Benzinga APIs.

Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $5.51 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.68 per share was 8.2% above analysts’ consensus estimates.

Wedbush analyst reiterates Apple as Outperform, sees $100B US investment as strategic move to ease tensions and secure growth amid tariffs.

McDonald's has found the perfect economic combo meal: a $5 deal that's not just feeding the masses—it's feeding its stock price.

Dentsply Sirona beat Q2 EPS and sales forecasts, drove margin expansion and EBITDA growth, reaffirmed FY25 guidance despite mixed segment performance and a share pullback.

Luxury furniture retailer Arhaus (NASDAQ:ARHS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.7% year on year to $358.4 million. Guidance for next quarter’s revenue was better than expected at $335 million at the midpoint, 0.9% above analysts’ estimates. Its GAAP profit of $0.25 per share was 65.6% above analysts’ consensus estimates.

Medical device company Zimmer Biomet (NYSE:ZBH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8% above analysts’ consensus estimates.

Howard Stern has been a key to the Sirius XM investment thesis. A potential exit in 2025 could spell trouble for the radio company and Warren Buffett.

The turnaround story at Peloton seems to be gaining momentum.

Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.8% year on year to $1.24 billion. Guidance for next quarter’s revenue was better than expected at $1.1 billion at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $0.26 per share was 29.5% above analysts’ consensus estimates.

Golf equipment and apparel company Acushnet (NYSE:GOLF) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 5.4% year on year to $720.5 million. Its GAAP profit of $1.25 per share was 4.7% below analysts’ consensus estimates.

Opendoor Technologies is facing a pivotal moment as it battles a U.S. housing market that the CEO described as "very challenging."

Real estate brokerage and services firm Marcus & Millichap (NYSE:MMI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 8.8% year on year to $172.3 million. Its GAAP loss of $0.28 per share was significantly below analysts’ consensus estimates.

Blood products company Haemonetics (NYSE:HAE). reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 4.4% year on year to $321.4 million. Its non-GAAP profit of $1.10 per share was 8.3% above analysts’ consensus estimates.

Medical technology company Enovis Corporation (NYSE:ENOV) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.5% year on year to $564.5 million. The company’s full-year revenue guidance of $2.26 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $0.79 per share was 9.9% above analysts’ consensus estimates.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active S&P500 stocks in today's session.

Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 32.9% year on year to $649.1 million. On top of that, next quarter’s revenue guidance ($671.7 million at the midpoint) was surprisingly good and 4.4% above what analysts were expecting. Its non-GAAP profit of $1.17 per share was 26.8% above analysts’ consensus estimates.